Searching for an ideal cervical cancer screening model to reduce false-negative errors in a country with high prevalence of cervical cancer
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Song, Taejong | - |
dc.contributor.author | Seong, Seok Ju | - |
dc.contributor.author | Lee, Seon-Kyung | - |
dc.contributor.author | Kim, Byoung-Ryun | - |
dc.contributor.author | Ju, Woong | - |
dc.contributor.author | Kim, Ki Hyung | - |
dc.contributor.author | Nam, Kyehyun | - |
dc.contributor.author | Sim, Jae Chul | - |
dc.contributor.author | Kim, Tae Jin | - |
dc.date.accessioned | 2021-08-11T08:37:35Z | - |
dc.date.available | 2021-08-11T08:37:35Z | - |
dc.date.issued | 2020-02-17 | - |
dc.identifier.issn | 0144-3615 | - |
dc.identifier.issn | 1364-6893 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/3090 | - |
dc.description.abstract | The purpose of this study was to develop an ideal cervical cancer screening model to reduce false-negative errors in Korea where there is a high prevalence of cervical cancer. We conducted a cross-sectional study including 33,531 women who underwent routine cervical cancer screening in Korea. Colposcopic examinations were performed after abnormal results on their screening tests. Diagnostic capacities including sensitivity, specificity, and false-negative rate of each screening scenario were analysed at the CIN1 or worse (CIN1+) threshold with colposcopic biopsy results considered the gold standard. A total of 4117 women had valid results for Papanicolaou (Pap) cytology, human papilloma virus (HPV) tests, cervicography, and colposcopically directed biopsy were included in this study. The disease prevalence of CIN1+ was 38.1%. Pap-alone resulted in the highest false-negative rate of 46.9%, followed by HPV-alone at 25.1%, cervicography-alone at 18.7%, Pap/HPV-combined at 15.0%, Pap/cervicography-combined at 6.9% and Pap/HPV/cervicography-combined at 2.9% in a sample of 1570 women with CIN1+ lesions. Therefore, cervicography demonstrated excellent performance for the detection of CIN or cervical cancer and markedly reduced false-negative errors when used in combination with Pap cytology and HPV tests.IMPACT STATEMENT What is already known on this subject? False-negative rate of Pap smears is as high as approximately 40-50%. Limitations of the Papanicolaou (Pap) test have led to the development of new screening programmes for cervical cancer, such as combination screenings with human papillomavirus (HPV) tests or cervicography. What do the results of this study add? Pap-alone resulted in the highest false-negative rate of 46.9%, followed by HPV-alone at 25.1%, cervicography-alone at 18.7%, Pap/HPV-combined at 15.0%, Pap/cervicography-combined at 6.9% and Pap/HPV/cervicography-combined at 2.9% in a sample of 1570 women with CIN1+ lesions. | - |
dc.format.extent | 7 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | Taylor & Francis | - |
dc.title | Searching for an ideal cervical cancer screening model to reduce false-negative errors in a country with high prevalence of cervical cancer | - |
dc.type | Article | - |
dc.publisher.location | 미국 | - |
dc.identifier.doi | 10.1080/01443615.2019.1621813 | - |
dc.identifier.scopusid | 2-s2.0-85079203520 | - |
dc.identifier.wosid | 000479355200001 | - |
dc.identifier.bibliographicCitation | Journal of Obstetrics and Gynaecology, v.40, no.2, pp 240 - 246 | - |
dc.citation.title | Journal of Obstetrics and Gynaecology | - |
dc.citation.volume | 40 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 240 | - |
dc.citation.endPage | 246 | - |
dc.type.docType | Article | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Obstetrics & Gynecology | - |
dc.relation.journalWebOfScienceCategory | Obstetrics & Gynecology | - |
dc.subject.keywordPlus | INTRAEPITHELIAL NEOPLASIA | - |
dc.subject.keywordPlus | CERVICOGRAPHY | - |
dc.subject.keywordPlus | WOMEN | - |
dc.subject.keywordAuthor | Uterine cervical neoplasms | - |
dc.subject.keywordAuthor | cytology | - |
dc.subject.keywordAuthor | cervicography | - |
dc.subject.keywordAuthor | human papillomavirus | - |
dc.subject.keywordAuthor | screening | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114
COPYRIGHT 2021 by SOONCHUNHYANG UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.